Evidence map›Paper›PMID 41455862›Full record

ArticleEJNMMI radiopharmacy and chemistry2025

Scale-up production of [

Sadahiro Naka, Tadashi Watabe, Yoshifumi Shirakami, Kazuhiro Ooe, Kenta Kurimoto, Toshihiro Sakai, Atsushi Toyoshima, Masashi Murakami, Yukiyoshi Kon, Hiromitsu Haba and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sadahiro NakaDepartment of Radiology, Graduate School of Medicine, the University of Osaka, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Tadashi WatabeDepartment of Radiology, Graduate School of Medicine, the University of Osaka, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan. watabe.tadashi.med@osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-8658-2395
Yoshifumi ShirakamiInstitute for Radiation Sciences, the University of Osaka, 2-4 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Kazuhiro OoeInstitute for Radiation Sciences, the University of Osaka, 2-4 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Kenta KurimotoDepartment of Radiology, Graduate School of Medicine, the University of Osaka, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Toshihiro SakaiHanwa Intelligent Medical Center, Hanwa Daini Senboku Hospital, 3176 Fukaikitamachi, Naka-ku, Sakai, 599-8271, Osaka, Japan.
Atsushi ToyoshimaInstitute for Radiation Sciences, the University of Osaka, 2-4 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Masashi MurakamiInstitute for Radiation Sciences, the University of Osaka, 2-4 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Yukiyoshi KonInstitute for Radiation Sciences, the University of Osaka, 2-4 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Hiromitsu HabaNishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198, Saitama, Japan.
Jens CardinaleDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Frederik L GieselDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Kayako IsohashiDepartment of Radiology, Graduate School of Medicine, the University of Osaka, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan.
Noriyuki TomiyamaDepartment of Radiology, Graduate School of Medicine, the University of Osaka, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan.

Funding

Japan Agency for Medical Reserch and Development JP23ym0126091
6 · The paper itself

Abstract

background[

resultsWe developed and optimized a scalable automated synthesis method for [

conclusionsThis study successfully established an automated, scalable production process for [

Indexed as

[211At]PSMA-5AstatineAutomated dry distillation and synthesis unitProstate cancerProstate specific membrane antigenScale-up manufacturingTargeted alpha therapy

Identifiers

PMID41455862
PMCPMC12852524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.